Your Article Summary
Glivec recommended for use in Europe as first post-surgery treatment for gastrointestinal stromal tumors
Novartis, 03/20/09
Novartis has received a positive opinion supporting European Union approval of Glivec as a post-surgery treatment for patients at significant risk of relapse following removal of gastrointestinal stromal tumors.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Zoster vaccination: A new opportunity for adult immunization
Canadian Journal of Infectious Diseases, 12/15/09
FDA Approves Newly Revised Prescribing Information For Azilect Reducing Medication And Food Restrictions
Teva Pharmaceutical Industries, 12/15/09
Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09
Article Search
Sponsor


See Latest Articles


